Cytek Biosciences, Inc.
CTKB· Nasdaq
Released Feb 23, 2022, after the close
10-K filed Mar 17, 2022, 76 days after period end · 0000950170-22-004106
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|
| Revenue | $38.89M | — |
| Net Income | -$1.17M | $5.60M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cytek Biosciences, Inc. · CIK 1831915 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Mar 17, 2022 · 76 d after period end